Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Beyond Medical Technologies Inc C.DOCT

Alternate Symbol(s):  DOCKF

Healthcare Cannabis
Beyond Medical Technologies Inc. is a Canada-based company. The Company has no business operations and has no revenue. The Company is seeking new business opportunities.


CSE:DOCT - Post by User

Beyond Medical Technologies Inc > No quarterly financials on Sedar... Again.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(9)
•••
Post by JocetooBadon Mar 09, 2022 11:29am
235 Views
Post# 34499540

No quarterly financials on Sedar... Again.

No quarterly financials on Sedar... Again.Last time DOCT posted their financial updates on Sedar was more than 3 months ago. I suppose they're not in a hurry to show crappy results once again. Anyone still holding this disaster?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities